Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > AMGN Amgen > Detailed Quotes

AMGN Amgen

Watchlist
253.650
-1.230-0.48%
Close  01/27 16:00 ET
253.6500.0000.00%
Post Mkt Price 01/27 16:22 ET
High
255.500
Open
254.870
Turnover
535.48M
Low
252.540
Pre Close
254.880
Volume
2.11M
Market Cap
135.34B
P/E(TTM)
20.36
52wk High
294.638
Shares
533.58M
P/E(Static)
24.67
52wk Low
209.602
Float Cap
135.07B
Bid/Ask %
80.00%
Historical High
294.638
Shs Float
532.49M
Volume Ratio
0.99
Historical Low
8.407
Dividend TTM
7.58
Div Yield TTM
7.04
P/B
37.05
Dividend LFY
2.99%
Div Yield LFY
2.78%
Turnover Ratio
0.40%
Amplitude
1.16%
Avg Price
253.800
Lot Size
1
Float Cap
135.07B
Bid/Ask %
80.00%
Historical High
294.638
Shs Float
532.49M
Volume Ratio
0.99
Historical Low
8.407
Dividend TTM
7.58
P/B
37.05
Dividend LFY
2.99%
Turnover Ratio
0.40%
Amplitude
1.16%
Avg Price
253.800
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, Aimovig, KANJINTI, EVENITY, AMGEVITA, AVSOLA, BLINCYTO, MVASI, Corlanor, Enbrel, EPOGEN, IMLYGIC, Kyprolis, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, Otezla, RIABNI, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
CEO: Mr. Robert A. Bradway
Market: NASDAQ
Listing Date: 06/01/1983
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist